Eric (Ric) Sinclair III Sells 40,225 Shares of Waystar (NASDAQ:WAY) Stock

Waystar Holding Corp. (NASDAQ:WAY) insider Eric (Ric) Sinclair III sold 40,225 shares of the company’s stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $30.08, for a total transaction of $1,209,968.00. Following the completion of the sale, the insider directly owned 474,826 shares in the company, valued at approximately $14,282,766.08. The trade was a 7.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Waystar Stock Performance

Shares of WAY stock opened at $29.98 on Friday. Waystar Holding Corp. has a 52-week low of $28.71 and a 52-week high of $48.11. The company has a quick ratio of 3.89, a current ratio of 3.89 and a debt-to-equity ratio of 0.38. The stock has a market cap of $5.74 billion, a PE ratio of 48.35, a price-to-earnings-growth ratio of 0.37 and a beta of 0.76. The business has a 50-day simple moving average of $33.04 and a 200-day simple moving average of $35.66.

Wall Street Analysts Forecast Growth

WAY has been the topic of a number of analyst reports. Mizuho raised their price objective on shares of Waystar from $48.00 to $50.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Zacks Research lowered shares of Waystar from a “strong-buy” rating to a “hold” rating in a research report on Thursday, January 1st. Wall Street Zen cut shares of Waystar from a “buy” rating to a “hold” rating in a report on Saturday, November 29th. UBS Group initiated coverage on shares of Waystar in a research note on Monday, December 15th. They set a “buy” rating and a $41.00 target price on the stock. Finally, BMO Capital Markets initiated coverage on Waystar in a research note on Thursday, November 13th. They issued an “outperform” rating and a $47.00 price target for the company. Two analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $46.64.

Hedge Funds Weigh In On Waystar

Several hedge funds and other institutional investors have recently added to or reduced their stakes in WAY. Vanguard Group Inc. increased its stake in shares of Waystar by 35.5% during the third quarter. Vanguard Group Inc. now owns 12,289,810 shares of the company’s stock worth $466,030,000 after purchasing an additional 3,219,586 shares in the last quarter. William Blair Investment Management LLC boosted its holdings in Waystar by 0.5% in the 3rd quarter. William Blair Investment Management LLC now owns 5,263,187 shares of the company’s stock worth $199,580,000 after buying an additional 23,822 shares during the last quarter. Alliancebernstein L.P. increased its stake in Waystar by 4.5% during the 3rd quarter. Alliancebernstein L.P. now owns 3,415,442 shares of the company’s stock worth $129,514,000 after buying an additional 146,510 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Waystar by 63.0% during the third quarter. Invesco Ltd. now owns 3,130,230 shares of the company’s stock valued at $118,698,000 after acquiring an additional 1,209,276 shares during the last quarter. Finally, Artisan Partners Limited Partnership purchased a new position in shares of Waystar in the third quarter valued at approximately $95,497,000.

About Waystar

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.